Although all HCL systems share the same principle of manual pre-prandial bolus administration and automated insulin dose adjustment in case of predicted hypo- or hyperglycemia, there are also several differences mainly related to glycemic targets, reaction to hyperglycemia and user adjustable settings. The gene discussed is INS; the disease is Hyperglycemia.